UPDATE: Piper Jaffray Reiterates Neutral Rating, Raises PT on Sequenom

In a report published Monday, Piper Jaffray & Co. reiterated its Neutral rating on Sequenom (NASDAQ: SQNM ), and slightly raised its price target from $4.50 to $5.00. Piper Jaffray noted, “Sequenom announced positive preliminary 2012 results, with revenue increasing ~59% year-over-year, implying 4Q12 revenue of ~$33M, favorable to both